New insights to enhance treatment and diagnosis of blood cancer

NUS scientists seek to exploit vulnerabilities in cancer development pathways to revolutionise treatment strategies for high-risk myeloma

2023-09-12

(Press-News.org) A ground-breaking study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) has revealed crucial insights into the role of the histone methyltransferase NSD2 and its epigenetic target PKCα in causing t(4;14) translocated multiple myeloma (MM), a high-risk subtype of blood cancer, to be more aggressive and resistant to treatment.

The study was led by Professor Wee Joo Chng, Senior Principal Investigator at CSI Singapore, and Dr Phyllis Chong Shu Yun, Senior Research Fellow at CSI Singapore. The research team discovered that NSD2 triggers elevated glycolysis through the activation of PKCα, leading to the production of excessive lactate that fuels malignancy and undermines response to immunomodulatory drugs. The findings present potential targets to improve the treatment of myeloma.

Targets for therapeutic intervention

Myeloma is the second most common blood cancer, and t(4;14) myeloma comprises 15 to 20 per cent of MM cases. Compared to other types of myeloma, patients with t(4;14) myeloma have a poorer prognosis with shorter overall survival. Unfortunately, the key deregulated gene in t(4;14) myeloma is not targetable with drugs.

“Our study aims to overcome the limitations of targeting the key deregulated gene in t(4;14) myeloma. It sheds light on the metabolic reprogramming of MM in response to the oxygen- and nutrient-deprived bone marrow microenvironment. By exploring the epigenome and metabolome of NSD2, we sought alternative vulnerabilities that could revolutionise treatment strategies,” said Prof Chng, lead author of the study.

The unique connection between NSD2 and cellular metabolism, mediated by histone methylation, offers new horizons in the battle against high-risk MM subtypes. The study’s impact is multifaceted, potentially influencing the development of novel medicines and non-invasive diagnostic tests. For patients with t(4;14) myeloma, targeted metabolic interventions could bring promising therapeutic options, whether through dietary modifications or tailored pharmacological approaches. Furthermore, the discovery that lactate levels could serve as predictive biomarkers for drug response highlights the transformative potential of metabolite signatures in personalised medicine.

Striving towards tailored interventions and personalised care

This study, which was published in Cancer Research, American Association for Cancer Research on 18 July 2023, marks a significant stride in unravelling the complexities of MM and holds promise to improving treatment outcomes for patients with high-risk subtypes.

Looking ahead, Prof Chng and his team plan to leverage the knowledge gained from this study to design therapeutic intervention for t(4;14) myeloma. The success of their metabolic characterisation of t(4;14) myeloma also paves the way for the team to extend their metabolomic framework to profile other genetically high-risk MM subtypes such as t(14;16) or with 1q21 amplifications, presenting a path towards tailored interventions and personalised care.

END

ELSE PRESS RELEASES FROM THIS DATE:

Gotcha! New technology speeds up bacterial testing in food

2023-09-12

It is said that there is waste in haste, but researchers from Osaka Metropolitan University have proven that doing things rapidly does not necessarily mean working ineffectively. A research group led by Professor Hiroshi Shiigi at the Graduate School of Engineering, Osaka Metropolitan University has developed a technology that can rapidly and accurately determine the number of viable bacteria in food products electrochemically, using tetrazolium salt (MTT), a water-soluble molecule. One of the most important assessment indicators for ensuring that food is free from contamination is the number of viable bacteria. However, conventional measurement methods take up to 2 days to yield results, ...

US teachers are less satisfied with their pay than most working adults

2023-09-12

Sixty-six percent of U.S. teachers who responded to a new, nationally representative RAND Corporation survey said their base salary was inadequate, compared with 39% of U.S. working adults. These teachers want a $17,000 increase in base pay, on average, to feel that their pay is adequate. This equates roughly to a 27% pay increase, which is comparable to the estimated gap in pay between teachers and other similarly college-educated workers, also known as the “teacher pay penalty.” In early 2023, RAND researchers surveyed public-school teachers about how salary and work hours affect ...

Targeted ultrasound can change brain functions for up to an hour after intervention

2023-09-12

The targeted use of ultrasound technology can bring about significant changes in brain function that could pave the way towards treatment of conditions such as depression, addiction, or anxiety, a new study suggests. Research by neuroscientists at the University of Plymouth explored the impacts of an emerging technique called transcranial ultrasound stimulation (TUS). Typically, ultrasound examinations involve diffuse broad beams of ultrasound being used to create images while leaving the target tissue unaffected. However, focusing the beams through TUS can increase the pressure in the target region and change the way ...

U.S. advocacy strategy nets a 25 percent increase in lung cancer research funding

2023-09-12

[Singapore, 10:05 a.m. SGT--September 12, 2023] - A unified and concentrated lung cancer advocacy program in the United States resulted in a 25 percent increase in funding to a U.S.-based lung cancer research program, according to a presentation given today at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer in Singapore. Lung cancer remains a major health concern, with mortality rates posing a significant challenge both globally and in the United States. The U.S. Department of Defense Congressionally Directed Medical Research Program/Lung Cancer Research Program (LCRP) was established in 2009 with a funding level of $20 million, but ...

IASLC staging model for mesothelioma validated; study supports continued use of model

2023-09-12

[Singapore, 10:05 a.m. SGT--September 12, 2023] – A model developed by the International Association for the Study of Lung Cancer in 2009 to help better stage mesothelioma cases performed well, according to an independent analysis presented today at The International Association for the Study of Lung Cancer (IASLC) 2023 Conference in Singapore. Pleural mesothelioma is a rare but aggressive cancer primarily caused by asbestos exposure and presents complex challenges for effective staging and prognostication. The IASLC took a significant step in 2009 by establishing an international pleural mesothelioma database aimed at enhancing staging ...

Long-term outcomes of radiation techniques for locally advanced non-small cell lung cancer presented at IASLC 2023 Conference in Singapore

2023-09-12

[Singapore, 10:05 a.m. SGT--September 12, 2023] - Intensity-modulated radiation therapy, or IMRT, should be utilized for locally advanced NSCLC to reduce the risk of severe pulmonary toxicity and radiation exposure to the heart, according to research presented today at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer in Singapore. Dr. Stephen Chun, MD Anderson in Houston, Texas, presented a comprehensive analysis of the phase III trial NRG Oncology-RTOG 0617, comparing intensity-modulated radiation therapy (IMRT) with 3D-conformal ...

Reproductive factors associated with higher risk of lung cancer in women

2023-09-12

[Singapore, 10:05 a.m. SGT--September 12, 2023] - A study presented at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer revealed that key reproductive factors such as early menopause, shortened reproductive span, and early age at first birth are associated with elevated risks of lung cancer in women. Researchers from Xiangya Hospital, Changsha, Hunan, China, conducted a prospective cohort study involving 273,190 participants from the UK Biobank to delve into the links between individual reproductive ...

Dark matter halos measured around ancient quasars

2023-09-12

At the center of every galaxy is a supermassive black hole. Beyond a certain size, these become active, emitting huge amounts of radiation, and are then called quasars. It is thought these are activated by the presence of massive dark matter halos (DMH) surrounding the galaxy, directing matter towards the center, feeding the black hole. A team including researchers from the University of Tokyo have, for the first time, surveyed hundreds of ancient quasars and found this behavior is very consistent throughout history. This is surprising, as many large-scale processes show variation throughout the ...

Arf1 inhibitors promote the infiltration of cytotoxic T lymphocytes into tumors by affecting lipid metabolism

2023-09-12

In recent years, cancer immunotherapies, represented by immune checkpoint blockade (ICB), have been highly successful and have become an important basis for the future treatment of cancers. However, the absence of tumoral killer T cells and the complexity of tumor microenvironment can both affect the immunotherapeutic efficacy. Therefore, it is urgent to develop novel anti-tumor agents that can effectively promote effector T cell infiltration in tumors. ADP-ribosylation factor 1 (Arf1) is a member of the Ras small GTPase family and is ...

Intensity-modulated radiation therapy provides long-term benefits to patients with locally advanced lung cancer

2023-09-12

Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the heart and lungs, according to researchers at The University of Texas MD Anderson Cancer Center. Results from a long-term secondary analysis of the NRG Oncology-RTOG 0617 Phase III study, with a median follow-up of 5.2 years, revealed that patients receiving IMRT had a more than two-fold reduction in severe lung inflammation (pneumonitis) compared to those who received 3D-conformal radiotherapy ...

LAST 30 PRESS RELEASES:

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC